Jon P. Stonehouse - 01 Sep 2022 Form 4/A - Amendment Insider Report for BELLICUM PHARMACEUTICALS, INC

Role
Director
Signature
/s/ Richard A. Fair, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
01 Sep 2022
Net transactions value
$0
Form type
4/A - Amendment
Filing time
04 Jan 2023, 19:08:09 UTC
Date Of Original Report
02 Sep 2022
Previous filing
16 Jun 2022
Next filing
02 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLCM Common Stock Options Exercise $0 +60,580 +275% $0.000000 82,634 01 Sep 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment is being filed to correct the mathematical error in the total amount of securities beneficially owned following the reported transaction on the original Form 4 filed with the SEC on September 2, 2022.